Kindling 4 pp 197-208 | Cite as

N-Methyl-D-Aspartate (NMDA) Receptors and the Kindling Model

  • James O. McNamara
  • Douglas W. Bonhaus
  • J. Victor Nadler
  • Geng-Chang Yeh
Part of the Advances in Behavioral Biology book series (ABBI, volume 37)


This chapter will consider recent pharmacologic, electrophysiologic, and biochemical studies examining the role of a subtype of excitatory amino receptor, the NMDA receptor, in the development of kindling and expression of kindled seizures.


NMDA Receptor Excitatory Amino Acid NMDA Antagonist Glycine Receptor NMDA Receptor Activation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nowak, L., Bregestovski, P., Ascher, P., Herbert, A., and Prochiantz, A., 1984, Magnesium gates glutamate-activated channels in mouse central neurons, Nature. 307: 462.PubMedCrossRefGoogle Scholar
  2. 2.
    Mayer, M.L., Westbrook, G.L., and Gutherie, P.B., 1984, Voltage-dependent block by magnesium of NMDA responses in spinal cord neurons. Nature. 309: 261.PubMedCrossRefGoogle Scholar
  3. 3.
    Herron, C.E., Lester, R.A., Coan, E.J., and Collingridge, J.L., 1985, Intracellular demonstration of an N-methyl-D-aspartate receptor mediated component of synaptic transmission in the rat hippocampus, Neurosci.Lett. 60: 19.PubMedCrossRefGoogle Scholar
  4. 4.
    Hynes, M.A. and Dingledine, R., 1984, Attenuation of epileptiform burst firing in the rat hippocampal slice by antagonists of N-methyl-D-aspartate receptors, Soc.Neurosci. Abst. 10: 229.Google Scholar
  5. 5.
    Croucher, M.J., Collins, J.F., and Meldrum, B.S., 1982, Anticonvulsant action of excitatory amino acid antagonists, Science 216: 899.PubMedCrossRefGoogle Scholar
  6. 6.
    Czuczwar, S.J. and Meldrum, B.S., 1982, Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid, Eur. J. Pharmacol. 83: 335.PubMedCrossRefGoogle Scholar
  7. 7.
    Cline, H.T., Debski, E.A., and Constantine-Paton, M., 1987, N-methyl-D-aspartate receptor antagonist desegregates eye-specific stripes, Proc.Natl.Acad.Sci. U.S.A. 84: 4342.PubMedCrossRefGoogle Scholar
  8. 8.
    Harris, E.W., Ganong, A.H., and Cotman, C.W., 1984, Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res. 323: 132.PubMedCrossRefGoogle Scholar
  9. 9.
    Morris, R.G.M., Anderson, E., Lynch. G.S., and Baudry, M., 1986, Selective impairment of learning and blockage of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5, Nature 319: 774.PubMedCrossRefGoogle Scholar
  10. 10.
    McNamara, J.O., Russell, R.D., Rigsbee, L., and Bonhaus, D.W., 1988, Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models, Neuropharmacology 27: 563.PubMedCrossRefGoogle Scholar
  11. 11.
    Callaghan, D.A. and Schwark, W.S., 1980, Pharmacological modification of amygdaloidkindled seizures, Neuropharmacolom, 19: 1131.Google Scholar
  12. 12.
    Bowyer, J.F., and Winters, E.D., 1981, The effects of various anesthetics on amygdaloid kindled seizures, Neuropharmacologv 20: 199.CrossRefGoogle Scholar
  13. 13.
    Bowyer, J.F., 1982, Phencyclidine inhibition of the rate of kindling development. Exp. Neurol. 75: 173.PubMedCrossRefGoogle Scholar
  14. 14.
    Bowyer, J.F., Albertson, T.E., Winters, W.D. and Baselt, R.C., 1983, Ketamine-induced changes in kindled amygdaloid seizures, Neuropharmacologv 22: 887.CrossRefGoogle Scholar
  15. 15.
    Holmes, K.H. and Goddard, G.B., 1986, A role for the N-methyl-D-aspartate receptor in kindling, Proc. Univ.Otago Med. Sch. 64: 37.Google Scholar
  16. 16.
    Cain, D.P., Desborough, K.A., McKitrick, D.J., 1988, Retardation of amygdaloid kindling by antagonism of NMD-aspartate and muscarinic cholinergic receptors: evidence for the summation of excitatory mechanisms in kindling, Exp. Neurol. 100: 203.PubMedCrossRefGoogle Scholar
  17. 17.
    Vezzanni, A., Wu, H.Q., Moneta, E., and Samanin, R., 1988, Role of the N-methyl-Daspartate-type receptors in the development and maintenance of hippocampal kindling in rats, Neurosci.Lett. 87: 63.CrossRefGoogle Scholar
  18. 18.
    Sato, K., Morimoto, K., and Okamoto, M., 1988, Anticonvulsant action of a noncompetitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy, Brain Res. 463: 12.PubMedCrossRefGoogle Scholar
  19. 19.
    Gilbert, M.E., 1988, The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures, Brain Res. 463: 90.PubMedCrossRefGoogle Scholar
  20. 20.
    McNamara, J.O., Shin, C., Butler, L., and Rigsbee, L.C., 1989, Intravenous phenytoin is an effective anticonvulsant in the kindling model, Annals of Neurol., in press.Google Scholar
  21. 21.
    Albright, P.S., and Burnham, W.M., 1980, Development of a new pharmacological seizure model: effects of anticonvulsants on cortical-and amygdala-kindled seizures in the rat, Epilepsia 21: 681.PubMedCrossRefGoogle Scholar
  22. 22.
    Albertson, T.E., Peterson, S.L., Stark, L.G., 1980, Anticonvulsant drugs and their antagonism of kindled amygdaloid seizures in rats, Neuropharmacology 19: 643.PubMedCrossRefGoogle Scholar
  23. 23.
    Mody, I. and Heinemann, U., 1987, NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling, Nature 326: 701.PubMedCrossRefGoogle Scholar
  24. 24.
    Baudry, M., Evans, M., Lynch, G., 1986, Excitatory amino acids inhibit stimulation of phosphoinositide metabolism by aminergic agonists in hippocampus, Nature 319: 329.PubMedCrossRefGoogle Scholar
  25. 25.
    Morrisett, R.A., Chow, C.C., Sakaguchi, T., Shin, C., and McNamara, J.O., 1989, Inhibition of muscarinic-coupled phosphoinositide hydrolysis by N-methyl-D-aspartate is dependent upon depolarization via channel activation. J. Neurochem., in press.Google Scholar
  26. 26.
    Mayer, M.L., and Westbrook, G.L., 1987, The physiology of excitatory amino acids in the vertebrate central nervous system, Prof.Neurobiol. 28: 197.CrossRefGoogle Scholar
  27. 27.
    Morrisett, R.A., Chow, C., Nadler, J.V., and McNamara, J.O., 1989, Biochemical evidence for enhanced sensitivity to N-methyl-D-aspartate in the hippocampal formation of kindled rats, Brain Res., in press.Google Scholar
  28. 28.
    Okazaki, M.M., McNamara, J.O., and Nadler, J.V., 1989, N-methyl-D-aspartate receptor autoradiography in rat brain after angular bundle kindling, Brain Res. 482: 359.PubMedCrossRefGoogle Scholar
  29. 29.
    Lambert, J.D.C., and Jones, R.S.G., 1989, Activation of N-methyl-D-aspartate receptors contributes to the EPSP at perforant path synapses in the rat dentate gyrus in vitro, Neurosci. Lett. 97: 323.PubMedCrossRefGoogle Scholar
  30. 30.
    Sakmann, B., Methfessel, C., Mishina, M., Takahashi, T., Takai, T., Kurasaki, M., Fukuda, K., Numa, S., 1985, Role of acetylcholine receptor subunits in fazing of the channel, Nature 318: 538.PubMedCrossRefGoogle Scholar
  31. 31.
    Mishina, M., Takai, T., Imoto, K., Takahashi, T., Numa, S., Methsessel, C. and Sakmann, B., 1986, Molecular distinction between fetal and adult form of muscle acetylcholine receptor, Nature 321: 406.PubMedCrossRefGoogle Scholar
  32. 32.
    Levitan, E.S., Schofield, P.R., Burt, D.R., Rhee, L.M., Wisden, W., Kohler, M., Fujita, N., Rodriguez, H.F., Stephenson, A., Darlison, M.D., Barnard, E.A., and Seebug, P.H. 1988, Structural and functional basis of GABAA receptor heretogeneity, Nature 335: 76.PubMedCrossRefGoogle Scholar
  33. 33.
    Geula, C., Harvie, P.A., Logan, T.C. and Slevin, J.R., 1988, Long-term enhancement of IC-evoked release of L-glutamate in entorhinal kindled rats, Brain Res., 442: 368.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • James O. McNamara
    • 1
    • 2
    • 3
  • Douglas W. Bonhaus
    • 1
    • 3
  • J. Victor Nadler
    • 2
  • Geng-Chang Yeh
    • 2
  1. 1.Departments of MedicineDuke University Medical CenterUSA
  2. 2.Departments of PharmacologyDuke University Medical CenterUSA
  3. 3.Veterans Administration Medical CenterDurhamUSA

Personalised recommendations